ADDRESS: Street, City, Country
PHONE: +(123) 456 789
E-MAIL: your-email@mail.com
Novo Nordisk plans to begin a phase 3 development programme for zenagamtide in adults with type 2 diabetes during the second half of 2026.
imphoenix82
Let’s explore how robotic surgery is evolving in India with Dr. Sudhir Srivastava, Chairman and CEO of SS Innovations.
dineshwori
The acquisition strengthens Photocure’s bladder cancer diagnostics portfolio by adding Vesica Health’s urine-based molecular diagnostic technology – AssureMDx.
imphoenix82
Mabwell said the NMPA has also accepted clinical trial applications for its antibody drug candidate, 9MW5211, in multiple sclerosis.
imphoenix82
The record-breaking 20,000-km robotic cardiac telesurgery was performed remotely between Georgetown Public Hospital in Guyana and IRCAD India in Indore by Dr. Sudhir Srivastava using the SSI Mantra Surgical Robotic System.
dineshwori
Dr. Syed Md. Ghouse of AINU performed what is being described as a world-first tele-robotic ureteric reimplantation from Wuhan on a patient in Hyderabad, nearly 3,900 km away.
imphoenix82
BPL Vent 300 – BPL Medical’s new ICU ventilator – features a high-performance turbine capable of delivering up to 240 L/min peak flow, enabling operation without dependence on a central gas supply.
imphoenix82
Reach Surgical said the ultrasonic shears device has been designed to improve ease of use and workflow efficiency during open surgeries, particularly thyroid and breast procedures.
imphoenix82
Lupin and Natco’s Eribulin Mesylate Injection – a generic version of Eisai’s Halaven Injection- is indicated for the treatment of adults with metastatic breast cancer who have previously received at least two chemotherapy regimens for metastatic disease.
imphoenix82
Now commercially available in Europe and Australia, the LBBOT Solution is intended to support physicians during pacing procedures, according to MicroPort.
imphoenix82HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 8447496924
HealthXploreIndia @2026. All Rights Reserved.
